TOXINS 2026: Program, Registration Fees, and Abstract Rules
TOXINS 2026, the International Neurotoxin Association’s (INA) eighth international conference on the basic science and clinical aspects of botulinum and other neurotoxins, took place January 14–17, 2026, at the Madrid Marriott Auditorium Hotel & Conference Center in Madrid, Spain. Registration and abstract submission are closed. (INA conference overview 🔗)
The next identified edition is TOXINS 2028. The fees, deadlines, and requirements below are records of the completed 2026 meeting, useful for understanding its scope and preparing questions for a future edition.
Scientific Program And Background Reading
Section titled “Scientific Program And Background Reading”The official 2026 program 🔗 retains the session timetable and a downloadable program. It combined basic science, clinical tracks, and workshops.
| 2026 program topic | What the topic concerns | Related reference |
|---|---|---|
| Adult and pediatric spasticity; cervical dystonia | Clinical treatment contexts and patient assessment | Limb spasticity, cervical dystonia |
| Migraine and headache | A dedicated clinical track | Chronic migraine |
| Aesthetics and dermatology | Clinical and anatomical discussions | Glabellar lines, anatomy overview |
| Clinical relevance of neutralizing antibodies | Immune responses and treatment response | Immunogenicity |
| Dosage conversion among different preparations | The evidence question surrounding product units | Unit interpretation |
| Botulinum toxin type E trials for glabellar lines | Research on another toxin type | Botulinum toxin type E |
| Toxin structure, neuron entry, and engineering | Basic science and experimental toxin development | Mechanism of action, toxin type differences |
A program entry establishes that a topic was scheduled, not the findings of the talk or the strength of its evidence. Study conclusions require the abstract or full paper; a conference listing does not establish an approved use or a product conversion ratio.
Abstract Records
Section titled “Abstract Records”INA’s homepage announcement 🔗 links the meeting abstracts to the Toxicon volume 271 supplement 🔗. Access conditions are controlled by the publisher. A session title is a starting point for locating research, rather than a substitute for reading its methods, results, and limitations.
Registration Fees And Inclusions
Section titled “Registration Fees And Inclusions”The 2026 registration schedule 🔗 listed these attendee fees in US dollars:
| Attendee category | INA member | Non-member |
|---|---|---|
| Early bird | $875 | $975 |
| Regular | $975 | $1,075 |
| On-site | $1,125 | $1,225 |
| Fellows/residents and postdoctoral fellows | $350 | $450 |
| Students | $150 | $250 |
Membership was free; academic discounts required credentials. Scientific sessions, exhibits, posters, materials, the reception, breakfast, and lunch were included. Accommodation was excluded. Exhibitor registrations were separate categories; the commercial exhibitor rate explicitly excluded session access.
Registration And Refund Dates
Section titled “Registration And Refund Dates”| 2026 registration milestone | Historical date |
|---|---|
| Early-bird registration | June 2–August 21, 2025 |
| Regular registration opened | August 22, 2025 |
| Individual/group registration closed | January 5, 2026, 11:59 p.m. Eastern Standard Time |
| On-site registration began | January 14, 2026 |
The cancellation policy offered 50% refunds through November 5, 2025, and 25% through November 19. It stated that no cancellations would be honored after November 20, 2025. These were past booking conditions, not refund terms for 2028. (INA registration and refund policy 🔗)
Abstract Submission Rules
Section titled “Abstract Submission Rules”The 2026 abstract instructions 🔗 set a deadline of October 24, 2025, at 11:59 p.m. Eastern Time. Submission is closed.
| Requirement | 2026 rule |
|---|---|
| Language and length | English; body up to 500 words; up to six keywords |
| File | Word, Arial 12-point; no PDF |
| Structure | Structured or unstructured abstracts accepted |
| Tables and figures | Editable text tables; captioned figures embedded in Word |
| Author information | Names, affiliations, corresponding-author contact details, and research funding |
| Submission route | Online portal; email and fax not accepted |
| Review | Rolling; status notification expected within six weeks |
Tables were excluded from the word count, as were the title, author information, footer, keywords, and financial support. The instructions linked a checklist and sample format.
Acceptance, Publication, And Attendance
Section titled “Acceptance, Publication, And Attendance”Encore submissions (previously presented work) were allowed, but abstracts accepted for TOXINS 2024 required updated data. Acceptance provided for publication in a Toxicon supplement, with copyright transfer to Elsevier. Attendance and poster presentation were optional; attending authors still had to register. These are historical conditions, not confirmed 2028 requirements. (INA abstract conditions 🔗)
Poster Presentation
Section titled “Poster Presentation”The official poster instructions 🔗 required registration for authors bringing a poster. Authors did not have to remain beside it during display hours.
| Poster requirement | 2026 specification |
|---|---|
| Maximum physical size | 1,828 mm wide × 1,219 mm high; landscape |
| Setup | January 14, 2026, 8:00 a.m.–5:00 p.m. |
| Mounting | Boards and double-sided tape supplied; poster IDs provided on site |
| Logos | INA, TOXINS 2026, and corporate logos excluded |
| Optional online poster | Web-ready PDF, maximum 2 MB; submission link requested before December 12, 2025 |
The optional virtual poster hall was described as available to attendees for six months after the conference. That historical access period does not establish that the posters remain available now. Abstract submission used Word; the PDF specification applied to the separate online poster.
Toxins 101 And Clinical Workshops
Section titled “Toxins 101 And Clinical Workshops”Toxins 101 ran on January 14, 2026, from noon to 4:00 p.m. It introduced clinical neurotoxin applications for clinicians with limited experience, including trainees, and interested basic scientists. Topics included mechanisms, spasticity, movement disorders, and case discussions. (INA Toxins 101 course 🔗)
The course had limited capacity and separate signup through an email sent to registered attendees. The announcement gave December 1 as the signup opening but did not specify an additional fee. Separate signup therefore establishes a booking step, not a confirmed surcharge.
The main program 🔗 also listed ultrasound workshops for the limbs and head and neck, plus injection demonstrations across several clinical areas. These entries describe educational activities; they do not establish a qualification or replace product-specific labeling and professional training.
For the next meeting, use the TOXINS 2028 planning guide for announcement status and preparation. The events overview connects the TOXINS series with broader neurology, rehabilitation, and aesthetic medicine meetings.

